CHINA PHARMACEUTICAL (fka CPICF)

[alan webber]

One of the possible merger targets


MCHEM PHARMA GROUP is a group of companies such as:
MCHEM Pharmaceutical Co.,Ltd.
Dafeng Pharmaceutical Chemical Co.,Ltd.
Shanghai Mchem New Drug Development Co., Ltd.

see their site:
http://www.mchem.com.cn/indexen.jsp

It is quite possible that one of these is the target for the reverse merger and hopefully we will know within 2 weeks.

We do not know or how they got the shares they sold to China M&A Management Holdings as they are not listed on the past 20-F as a shareholder.


China M&A Management Holdings bought 3,929,450 shares from Global China Enterprises Limited so seems likely to be working on the reverse merger.

What we know now is that if the merger is a go that it will be soon and that a Merger and Acquisition firm now holds about 5% of the stock at 15 cents and is looking to make far greater then that value for sure.

We know that some Chinese companies in the drug area are doing very well. SVA with similar number of shares to CPICF has only $6M in revs and stock price of $3.80 and AOB with same number of shares at a stock price of $4.75

CPICF is not yet known but as most of the shares are owned by insiders there are very few available to trade, once a merger does take place the price can jump to its value directly and overnight.